VISHEE(SH:688580) Xin Lang Cai Jing·2025-11-12 02:15Core Insights - Weisi Medical's stock price increased by 2.14% on November 12, reaching 49.20 CNY per share, with a market capitalization of 4.712 billion CNY [1] - The company has seen an 81.48% increase in stock price year-to-date, but has experienced a decline of 3.40% over the last five trading days [1] Company Overview - Nanjing Weisi Medical Technology Co., Ltd. was established on January 10, 2001, and went public on July 21, 2020 [2] - The company specializes in the research, development, production, and sales of rehabilitation medical devices, focusing on areas such as pelvic floor and postpartum rehabilitation, neurological rehabilitation, and mental rehabilitation [2] - Revenue composition includes: magnetic stimulation (39.44%), consumables and accessories (19.42%), electrophysiology (19.18%), laser radiofrequency (10.26%), electrical stimulation (8.42%), and others (3.28%) [2] Financial Performance - For the period from January to September 2025, Weisi Medical reported revenue of 326 million CNY, a year-on-year increase of 11.58%, and a net profit attributable to shareholders of 102 million CNY, a year-on-year growth of 30.68% [2] - The company has distributed a total of 386 million CNY in dividends since its A-share listing, with 226 million CNY distributed over the past three years [3]